# Intraperitoneal Paclitaxel-loaded TPM for Treatment of Peritoneal Carcinomatosis

> **NCT05159050** · PHASE1 · TERMINATED · sponsor: **Carlos Chan** · enrollment: 4 (actual)

## Conditions studied

- Peritoneal Carcinomatosis

## Interventions

- **DRUG:** Paclitaxel-loaded tumor penetrating microparticles

## Key facts

- **NCT ID:** NCT05159050
- **Lead sponsor:** Carlos Chan
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-04-26
- **Primary completion:** 2024-03-17
- **Final completion:** 2025-12-09
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Drug supply issues
- **Last updated:** 2026-02-25

## Collaborators

- Institute of Quantitative Systems Pharmacology (IQSP)

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05159050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05159050, "Intraperitoneal Paclitaxel-loaded TPM for Treatment of Peritoneal Carcinomatosis". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT05159050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*